Haemonetics Secures U.S. Supply Agreement With CSL Plasma
Haemonetics Corporation has signed a U.S. supply agreement with CSL Plasma, with rollout expected by the end of 2027. Shares fell 1.75%.
Company news
Every story explained in plain English, with the prices that matter beside it.
Xplora Technologies AS Schedules Virtual Extraordinary General Meeting to Elect New Board Chair
Xplora Technologies AS scheduled a virtual extraordinary general meeting for October 23 to elect a new board chair and resolve leadership uncertainty.
TransUnion Launches First Look Tool to Lower Mortgage Lender Credit Score Costs
TransUnion introduced a credit insight review tool to help mortgage lenders lower origination costs by previewing data before buying scores.
TransUnion Launches Credit Check Tool to Reduce Mortgage Origination Costs
TransUnion has launched First Look Functionality for Mortgage to help lenders review credit reports before buying scores, lowering loan origination costs.
Perspective Therapeutics Receives FDA Fast Track Status for Cancer Treatment PSV359
Perspective Therapeutics received FDA Fast Track designation for its cancer drug PSV359, which could speed up development and review.
FDA Grants Fast Track Designation to Perspective Therapeutics Cancer Treatment
Perspective Therapeutics received FDA Fast Track designation for its cancer therapy PSV359, sending its shares up over 4%.
Pfizer to Cut 330 Jobs and Close Penicillin Unit at Italian Plant
Pfizer Inc. will close its penicillin department and lay off 330 workers at its Catania plant in Sicily as part of a restructuring plan.
Parsons Xtreme Golf Launches Torpedo ZT Putter With Zero Torque Technology
Parsons Xtreme Golf has released the Torpedo ZT putter, bringing zero-torque technology to a mallet design to improve stability.
Company newsNeutral
News Corporation Deploys $520 Million of $1 Billion Share Buyback Program
News Corporation has spent about $520 million of its $1 billion stock repurchase program to enhance shareholder value.
Valion Bio Raises $50,000 From 3i in Private Placement of Series B Preferred Shares
Valion Bio, Inc. secured $50,000 through a private sale of preferred shares and warrants to 3i to support its ongoing business operations.
Prudential Discloses ¥3.08 Billion in Misconduct Reimbursements and Executive Pay Cuts
Prudential Financial released an investigation report detailing billions of yen in customer refunds and pay cuts for top executives in Japan.
New Era Energy & Digital Secures $116 Million Letter of Credit From Macquarie Bank
New Era Energy & Digital, Inc. secured a $116 million letter of credit from Macquarie Bank to support PowerCo's power purchase agreement obligations.
Texas Ventures Acquisition III Secures $250,000 Working Capital Note From Yorkville
Texas Ventures Acquisition III has secured a $250,000 interest-free convertible note from Yorkville to boost its working capital.
Quetta Acquisition Corp. Delays Special Meeting to October 9 to Gather More Votes
Quetta Acquisition Corp. has postponed its special meeting to October 9 to solicit additional proxies, while preserving the September 22 record date.
Eva Live Secures Up to $1.88 Million Convertible Note Financing From Dune Equity
Eva Live Inc. has secured a 12% convertible note of up to $1.88 million from Dune Equity to fund business development and boost working capital.
Oil-Dri Corporation of America Expands Credit Facilities and Extends Debt Maturities
Oil-Dri Corporation of America expanded its credit facilities to increase liquidity and fund upcoming growth and acquisition initiatives.
PRA Group Issues 400 Million Dollars in Senior Notes to Refinance Debt
PRA Group, Inc. has issued 400 million dollars in senior notes to pay off its revolving credit line, extending debt maturities and boosting liquidity.
BNP Paribas Crosses Shareholding Threshold in easyJet
easyJet plc has been notified that BNP Paribas crossed a major ownership threshold, a move that could affect investor sentiment and share float.
AngioDynamics Appoints Eric Honroth as President and CEO
AngioDynamics, Inc. has named Eric Honroth as its new President and CEO, effective November 2, 2026, to drive growth and margin expansion.
AngioDynamics Names Eric Honroth as President and CEO
AngioDynamics has named industry veteran Eric Honroth as its new CEO to lead the medical technology company's next phase of growth and transition.